Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
How do I transition a patient from fedratinib to momelotinib?
How do I transition a patient from fedratinib to momelotinib?
Fuente:
Zenodo
Saved in:
Bibliographic Details
Main Author:
Tripdatabase
Format:
Recurso digital
Published:
Zenodo
2026
Subjects:
fedratinib
momelotinib
drug transition
oncology
pharmacology
patient management
hematologic malignancies
myelofibrosis
treatment transition
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://doi.org/10.5281/zenodo.20330102
Similar Items
What are the clinical benefits and potential disadvantages of switching from fedratinib to momelotinib in the management of myelofibrosis?
by: Tripdatabase
Published: (2026)
What is the recommended dose adjustment for doxorubicin in patients on RCHOP who are stable on fluoxetine?
by: Tripdatabase
Published: (2026)
What is neuroleptic malignant syndrome?
by: Tripdatabase
Published: (2026)
What is the recommended protocol for switching a patient from olanzapine to aripiprazole?
by: Tripdatabase
Published: (2026)
What drugs are most effective for reducing agitation in hospital patients?
by: Tripdatabase
Published: (2026)